Welcome!

Agile Computing Authors: Elizabeth White, Liz McMillan, Yeshim Deniz, Pat Romanski, Andy Thurai

News Feed Item

Stock Sector Focuses On Record Sales of NovaBay's Avenova(R) in Interview With Sales and Marketing VP

In an interview With ​Stock-Sector ​at the American Academy of Ophthalmology Meeting in Las Vegas, NovaBay's Glenn Moro Explains Why Sales of ​Avenova ​Eyelid and Eyelash Cleanser Reached a Record $1.1 Million in the Third Quarter -- and Continue to Climb

NEW YORK, NY--(Marketwired - November 16, 2015) - STOCK-SECTOR.COM, ​an online source of news about promising medical, technology and energy companies, today released an interview with Glenn Moro, Vice President of Avenova®Sales and Marketing at ​NovaBay Pharmaceuticals ​(NYSE: NBY), an Emeryville, CA, a biopharmaceutical company commercializing and developing topical non­antibiotic antimicrobial products for the global eye care market.

Stock ­Sector caught up with Moro at the ​American Academy of Ophthalmology meeting​in Los Vegas, Nov. 14­-17, where NovaBay is discussing the benefits-and the rapidly rising sales-of its innovative eyelid and eyelash cleanser, ​Avenova®.

As Moro said in the interview ​[VIDEO] ​"We just had our biggest quarter ever, with $1.1 million in sales." Those third quarter numbers represented a 40% jump over second quarter sales. Moreover, fourth quarter sales are expected to rise at an even faster rate: Sales in the first month were 50% higher than those in the first month of the third quarter. "We are showing a nice trend -- and we are very excited," said Moro.

In the interview Moro explained that revenues come from both selling ​Avenovadirectly to doctors (who then bill their patients) and selling the eyelid cleanser through pharmacies after doctors write prescriptions. The prescription side of the business is growing the fastest. In January 2015, doctors were writing just a couple hundred prescriptions per month. "Now we're up to 6500 a month," Moro said. "We really excited about the prescription business. We believe it will be the majority of the business in the future."

Avenovasales are climbing for two reasons, Moro said. One is that the product is unique. Avenovais the only eyelid cleanser to contain Neutrox, NovaBay's proprietary pure hypochlorous acid (HOCl). While other products may include HOCl among their ingredients, they also contain substances like bleach, which is both less effective against microbes than Neutrox in lab tests and is toxic to cells. In vitro testing shows that Neutrox not only kills many strains of bacteria in seconds, it also neutralizes the toxins that the microbes produce, while being completely safe.

The second reason is that both ​patients​ and ​doctors​ have found that a regimen of daily lid hygiene using ​Avenovahas been remarkably successful in managing often ­painful eye conditions like blepharitis and meibomian gland dysfunction (or dry eye). Those conditions are caused by bacteria on the eyelids and affect an estimated 30 million Americans. Once doctors actually try Avenova, any skepticism they might have had about the product vanishes, said Moro. Many of their patients say that the product has brought the first relief they've had in years. ​Avenova, Moro said, "has had a profound impact on patients' lives."

That's why NovaBay is working so hard to get the word out to more doctors about the benefits of Avenova-and why Moro expects that 2016 will bring "a significant increase in sales."

Stock­-Sector is an online source of news about promising medical, technology, and energy companies. ​Stock­-Sector was created out of necessity, to provide a glimpse of the financial markets in sectors relevant to the investor. We strive to deliver easily digestible content to the overburdened stockholder. Another significant focus of ours is to establish compelling media to heighten the experience in neglected humdrum industries.

The statements contained herein may include statements of future expectations and other forward­looking statements that are based on management's current views and assumptions and involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. In addition to statements which are forward­looking by reason of context, the words "may", "will", "should," "expects," "plans," "intends," "anticipates," "believes," "estimates," "predicts," "potential," or "continue" and similar expressions identify forward­looking statements.

Actual results, performance or events may differ materially from those in such statements due to, without limitation, (i) general economic conditions, (ii) performance of financial markets, including emerging markets, and including market volatility, liquidity and credit events (iii) the frequency and severity of insured loss events, including from natural catastrophes and including the development of loss expenses, (iv) mortality and morbidity levels and trends, (v) persistency levels, (vi) the extent of credit defaults, (vii) interest rate levels, (viii) currency exchange rates including the Euro/U.S. Dollar exchange rate, (ix) changing levels of competition, (x) changes in laws and regulations, (xi) changes in the policies of central banks and/or foreign governments, (xii) the impact of acquisitions, including related integration issues, (xiii) reorganization measures, and (xiv) general competitive factors, in each case on a local, regional, national and/or global basis.

Embedded Video Available: https://youtu.be/7Dtyx7H9-lY

Contact Stock-Sector [email protected] for more information.

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

IoT & Smart Cities Stories
SYS-CON Events announced today that CrowdReviews.com has been named “Media Sponsor” of SYS-CON's 22nd International Cloud Expo, which will take place on June 5–7, 2018, at the Javits Center in New York City, NY. CrowdReviews.com is a transparent online platform for determining which products and services are the best based on the opinion of the crowd. The crowd consists of Internet users that have experienced products and services first-hand and have an interest in letting other potential buye...
In his general session at 19th Cloud Expo, Manish Dixit, VP of Product and Engineering at Dice, discussed how Dice leverages data insights and tools to help both tech professionals and recruiters better understand how skills relate to each other and which skills are in high demand using interactive visualizations and salary indicator tools to maximize earning potential. Manish Dixit is VP of Product and Engineering at Dice. As the leader of the Product, Engineering and Data Sciences team at D...
We are seeing a major migration of enterprises applications to the cloud. As cloud and business use of real time applications accelerate, legacy networks are no longer able to architecturally support cloud adoption and deliver the performance and security required by highly distributed enterprises. These outdated solutions have become more costly and complicated to implement, install, manage, and maintain.SD-WAN offers unlimited capabilities for accessing the benefits of the cloud and Internet. ...
"IBM is really all in on blockchain. We take a look at sort of the history of blockchain ledger technologies. It started out with bitcoin, Ethereum, and IBM evaluated these particular blockchain technologies and found they were anonymous and permissionless and that many companies were looking for permissioned blockchain," stated René Bostic, Technical VP of the IBM Cloud Unit in North America, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Conventi...
René Bostic is the Technical VP of the IBM Cloud Unit in North America. Enjoying her career with IBM during the modern millennial technological era, she is an expert in cloud computing, DevOps and emerging cloud technologies such as Blockchain. Her strengths and core competencies include a proven record of accomplishments in consensus building at all levels to assess, plan, and implement enterprise and cloud computing solutions. René is a member of the Society of Women Engineers (SWE) and a m...
DXWordEXPO New York 2018, colocated with CloudEXPO New York 2018 will be held November 11-13, 2018, in New York City and will bring together Cloud Computing, FinTech and Blockchain, Digital Transformation, Big Data, Internet of Things, DevOps, AI, Machine Learning and WebRTC to one location.
In an era of historic innovation fueled by unprecedented access to data and technology, the low cost and risk of entering new markets has leveled the playing field for business. Today, any ambitious innovator can easily introduce a new application or product that can reinvent business models and transform the client experience. In their Day 2 Keynote at 19th Cloud Expo, Mercer Rowe, IBM Vice President of Strategic Alliances, and Raejeanne Skillern, Intel Vice President of Data Center Group and G...
DXWorldEXPO LLC announced today that All in Mobile, a mobile app development company from Poland, will exhibit at the 22nd International CloudEXPO | DXWorldEXPO. All In Mobile is a mobile app development company from Poland. Since 2014, they maintain passion for developing mobile applications for enterprises and startups worldwide.
Founded in 2000, Chetu Inc. is a global provider of customized software development solutions and IT staff augmentation services for software technology providers. By providing clients with unparalleled niche technology expertise and industry experience, Chetu has become the premiere long-term, back-end software development partner for start-ups, SMBs, and Fortune 500 companies. Chetu is headquartered in Plantation, Florida, with thirteen offices throughout the U.S. and abroad.
DXWorldEXPO | CloudEXPO are the world's most influential, independent events where Cloud Computing was coined and where technology buyers and vendors meet to experience and discuss the big picture of Digital Transformation and all of the strategies, tactics, and tools they need to realize their goals. Sponsors of DXWorldEXPO | CloudEXPO benefit from unmatched branding, profile building and lead generation opportunities.